Commentary on “Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial Fibrillation”
- 15 July 2025
- journal article
- Published by Wiley in Journal of Cardiovascular Electrophysiology
- Vol. 36 (8) , 2103-2104
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Sodium‐Glucose Cotransporter‐2 Inhibitors and Stroke Risk in Patients With Atrial FibrillationJournal of Cardiovascular Electrophysiology, 2025
- Neutrophil-to-Lymphocyte Ratio, Lymphocyte-to-Monocyte Ratio and Platelet-to-Lymphocyte Ratio as Predictors of Short- and Long-Term Outcomes in Ischemic Stroke Patients with Atrial FibrillationJournal of Inflammation Research, 2024
- 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice GuidelinesCirculation, 2024
- A systematic review of validated methods for identifying cerebrovascular accident or transient ischemic attack using administrative dataPharmacoepidemiology and Drug Safety, 2012
- Immortal Time Bias in PharmacoepidemiologyAmerican Journal of Epidemiology, 2007